Showing 2640 results
- Media Release /Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1 PROS is a spectrum of rare conditions and is…
- Media Release /Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines1,4Cost savings from Lenalidomide Sandoz can expand treatment options for…
- Key Release /Ad hoc announcement pursuant to Art. 53 LR Q4 sales grew +6% (cc1, +4% USD) and core operating income grew +12% (cc, +9% USD) IM sales grew +7% (cc, +5% USD) and core operating income +15% (cc, +12…
- Statement /
- Featured News /
Novartis announces the company’s fourth quarter and 2021 full year financial results.
- Statement /
Form 483 posting by US Food and Drug Administration (FDA) – Novartis statement
- Media Library /
- Story /
Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
- Featured News /
Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.
Pagination
- ‹ Previous page
- 1
- …
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- …
- 264
- › Next page